Online Exclusives

Online Exclusives

Comparing Bortezomib-Based Triplet Combinations for Newly Diagnosed Multiple Myeloma

The first head-to-head trial of bortezomib-based triplet combination therapies for patients with newly diagnosed multiple myeloma (MM) found that induction with a combination of...

Researchers Develop Nanoscale Ultrasound Procedure for Cancer Research

Researchers at the University of Nottingham in the United Kingdom have developed an ultrasound imaging technique that uses sound rather than light to view...

European Union Approves New Hemophilia Recombinant Factor Product

The European Commission approved Kovaltry™ antihemophilic factor (recombinant) for the treatment of hemophilia A in patients of all ages. The drug is an unmodified...

FDA Grants Orphan Designation to ES-3000 for AML

The U.S. Food and Drug Administration granted a second orphan drug designation to ES-3000 (an orally bioavailable small molecule) for the treatment of acute...

CAR T-Cell Therapy Induces Complete Remissions in Aggressive Non-Hodgkin Lymphoma

In the phase II ZUMA-1 trial of patients with aggressive non-Hodgkin lymphoma, treatment with the experimental chimeric antigen receptor T-cell (CAR T-cell) therapy, KTE-C19,...

ABIM Survey Shows Majority of Physicians’ Want Shorter, More Frequent MOC Exams

The American Board of Internal Medicine (ABIM) surveyed board-certified physicians about potential changes to the Maintenance of Certification (MOC) program requirements, and the results...

FDA Approves Implant for the Treatment of Opioid Dependence

The U.S. Food and Drug Administration approved the first buprenorphine implant for the maintenance treatment of opioid dependence. The implant, which consists of four,...

FDA Accepts Application to Review New Sickle Cell Disease Treatment

The U.S. Food and Drug Administration (FDA) accepted a New Drug Application (NDA) from Emmaus Life Sciences for its orally administered pharmaceutical grade L-glutamine...

Study Finds Hematopoietic Cell Transplants May Age Immune Cells

A study funded by the National Institutes of Health found that certain blood cancer treatments may lead to the premature aging of immune cells. Researchers...

Study Finds Patients Are Less Physically Active One Year After Cancer Diagnosis

Research has shown that physical activity can help reduce cancer risk, and can help maintain quality of life and accelerate recovery after a cancer...
Advertisement

Current Issue

June 2019, Volume 5, Issue 7

This issue features a debate about new treatment options for beta-thalassemia, a look at what’s driving skyrocketing drug prices in myeloma, and more.